HIV-1 Tat Vaccines: information for government agencies


	HOME

	HIV and AIDS

		What is "AIDS"
		Routes of infection
		First symptoms
		Having AIDS
		Can AIDS be cured?

	The Need for Vaccines
		AIDS in the World
		AIDS in Africa

	HIV-1 Tat:

	A NOVEL APPROACH TO VACCINATION

		Scientific Background & Rationale
		HIV-1 Tat Protein
		Pre-clinical Studies
		Clinical Studies
		International Collaborations

	TAT VACCINE CANDIDATES

		1st. Gen.: Tat alone
		2nd Gen.: Tat+Microparticles
		2nd Gen.: Tat+Env
		Discovery Phase Leads

	MANUFACTURING

	CLINICAL TRIAL PLANS

	INTELLECTUAL PROPERTY

	NEWS

INFORMATION FOR GOVERNMENT AGENCIES

If you belong to a government agency and have the desire to know more about the ongoing research and/or clinical activities at the National AIDS Center of the Italian NIH, please send an email to cnaids@iss.it .